Molecular and Translational Cardiology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
Mitochondria and Metabolism Center, Department of Anaesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.
Nat Rev Cardiol. 2023 Dec;20(12):812-829. doi: 10.1038/s41569-023-00887-x. Epub 2023 May 26.
Cardiac metabolism is vital for heart function. Given that cardiac contraction requires a continuous supply of ATP in large quantities, the role of fuel metabolism in the heart has been mostly considered from the perspective of energy production. However, the consequence of metabolic remodelling in the failing heart is not limited to a compromised energy supply. The rewired metabolic network generates metabolites that can directly regulate signalling cascades, protein function, gene transcription and epigenetic modifications, thereby affecting the overall stress response of the heart. In addition, metabolic changes in both cardiomyocytes and non-cardiomyocytes contribute to the development of cardiac pathologies. In this Review, we first summarize how energy metabolism is altered in cardiac hypertrophy and heart failure of different aetiologies, followed by a discussion of emerging concepts in cardiac metabolic remodelling, that is, the non-energy-generating function of metabolism. We highlight challenges and open questions in these areas and finish with a brief perspective on how mechanistic research can be translated into therapies for heart failure.
心脏代谢对于心脏功能至关重要。由于心脏收缩需要大量持续供应的 ATP,因此人们主要从能量产生的角度来考虑燃料代谢在心脏中的作用。然而,衰竭心脏中代谢重塑的后果不仅限于能量供应受损。重新布线的代谢网络会产生代谢物,这些代谢物可以直接调节信号级联、蛋白质功能、基因转录和表观遗传修饰,从而影响心脏的整体应激反应。此外,心肌细胞和非心肌细胞的代谢变化都有助于心脏病理的发展。在这篇综述中,我们首先总结了不同病因引起的心脏肥大和心力衰竭中能量代谢的变化,然后讨论了心脏代谢重塑的新观点,即代谢的非能量产生功能。我们强调了这些领域的挑战和未解决的问题,并简要展望了如何将机制研究转化为心力衰竭的治疗方法。